Back to results
Not yet recruitingPhase 1Phase 2

Sustained Release Oral Formulation For Treatment Of Parkinsons Disease

NCT07709741

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

University of Minnesota

Minneapolis, Minnesota, United States

Contact

Khalaf Bushara, MD, FRCP

‪(612) 460-5734‬umnstudies@gmail.com
View on ClinicalTrials.gov
Sustained Release Oral Formulation For Treatment Of Parkinsons Disease — TrialFind